Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
15 result(s) for "Alhussain, Hashim"
Sort by:
Breathing Clean Air: Navigating Indoor Air Purification Techniques and Finding the Ideal Solution
The prevalence of airborne pathogens in indoor environments presents significant health risks due to prolonged human occupancy. This review addresses diverse air purification systems to combat airborne pathogens and the factors influencing their efficacy. Indoor aerosols, including bioaerosols, harbor biological contaminants from respiratory emissions, highlighting the need for efficient air disinfection strategies. The COVID-19 pandemic has emphasized the dangers of airborne transmission, highlighting the importance of comprehending how pathogens spread indoors. Various pathogens, from viruses like SARS-CoV-2 to bacteria like Mycobacterium (My) tuberculosis, exploit unique respiratory microenvironments for transmission, necessitating targeted air purification solutions. Air disinfection methods encompass strategies to reduce aerosol concentration and inactivate viable bioaerosols. Techniques like ultraviolet germicidal irradiation (UVGI), photocatalytic oxidation (PCO), filters, and unipolar ion emission are explored for their specific roles in mitigating airborne pathogens. This review examines air purification systems, detailing their operational principles, advantages, and limitations. Moreover, it elucidates key factors influencing system performance. In conclusion, this review aims to provide practical knowledge to professionals involved in indoor air quality management, enabling informed decisions for deploying efficient air purification strategies to safeguard public health in indoor environments.
Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA
To circumvent the limited availability of RNA extraction reagents, we aimed to develop a protocol for direct RT-qPCR to detect SARS-CoV-2 in nasopharyngeal swabs without RNA extraction. Nasopharyngeal specimens positive for SARS-CoV-2 and other coronaviruses collected in universal viral transport (UVT) medium were pre-processed by several commercial and laboratory-developed methods and tested by RT-qPCR assays without RNA extraction using different RT-qPCR master mixes. The results were compared to that of standard approach that involves RNA extraction. Incubation of specimens at 65°C for 10 minutes along with the use of TaqPath™ 1-Step RT-qPCR Master Mix provides higher analytical sensitivity for detection of SARS-CoV-2 RNA than many other conditions tested. The optimized direct RT-qPCR approach demonstrated a limit of detection of 6.6x103 copy/ml and high reproducibility (co-efficient of variation = 1.2%). In 132 nasopharyngeal specimens submitted for SARS-CoV-2 testing, the sensitivity, specificity and accuracy of our optimized approach were 95%, 99% and 98.5%, respectively, with reference to the standard approach. Also, the RT-qPCR CT values obtained by the two methods were positively correlated (Pearson correlation coefficient r = 0.6971, p = 0.0013). The rate of PCR inhibition by the direct approach was 8% compared to 9% by the standard approach. Our simple approach to detect SARS-CoV-2 RNA by direct RT-qPCR may help laboratories continue testing for the virus despite reagent shortages or expand their testing capacity in resource limited settings.
Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review
The prevalence of patients admitted to intensive care units (ICUs) with SARS-CoV-2 infection who were prescribed antibiotics is undetermined and might contribute to the increased global antibiotic resistance. This systematic review evaluates the prevalence of antibiotic prescribing in patients admitted to ICUs with SARS-CoV-2 infection using PRISMA guidelines. We searched and scrutinized results from PubMed and ScienceDirect databases for published literature restricted to the English language up to 11 May 2021. In addition, we included observational studies of humans with laboratory-confirmed SARS-CoV-2 infection, clinical characteristics, and antibiotics prescribed for ICU patients with SARS-CoV-2 infections. A total of 361 studies were identified, but only 38 were included in the final analysis. Antibiotic prescribing data were available from 2715 patients, of which prevalence of 71% was reported in old age patients with a mean age of 62.7 years. From the reported studies, third generation cephalosporin had the highest frequency amongst reviewed studies (36.8%) followed by azithromycin (34.2%). The estimated bacterial infection in 12 reported studies was 30.8% produced by 15 different bacterial species, and S. aureus recorded the highest bacterial infection (75%). The fundamental outcomes were the prevalence of ICU COVID-19 patients prescribed antibiotics stratified by age, type of antibiotics prescribed, and the presence of co-infections and comorbidities. In conclusion, more than half of ICU patients with SARS-CoV-2 infection received antibiotics, and prescribing is significantly higher than the estimated frequency of identified bacterial co-infection.
Risk Management Assessments and Recommendations Among Students, Staffs, and Health Care Workers in Educational Biomedical Laboratories
Safety in laboratories is one of the most crucial topics for all educational institutes. All-hazards need to be identified, evaluated, and controlled whenever possible, following the risk management (RM) process. This study evaluates two academic laboratories' risks and safety in the Department of Biomedical Science (BMS) at Qatar University (QU). The goal is to eliminate or reduce any risks to the students, teaching assistants, laboratory technicians, faculties, and other related workers, following an RM process. A cross-sectional study was performed from January to March 2020 in the BMS at QU. The study sample comprised of microbiology and hematology laboratories. Checklists and data collection sheets were used for data collection. Hazard evaluation failure mode and effects analysis (FMEA) was used. The risk priority number (RPN) was calculated for all the identified hazards. For hazard control, the hierarchy of controls was followed. The number of identified hazards was thirteen (n=13) in the hematology laboratory and sixteen (n=16) in the microbiology laboratory. Chemical and ergonomic hazards had the highest percentages in both laboratories, with 25% in the microbiology laboratory and 31% in the hematology laboratory. Both laboratories were free from radiation hazards. There is a significant difference between adopted and recommended control measures in each laboratory in terms of likelihood, severity, and risk priority number (RPN). Both chemical and ergonomic hazards account for almost a quarter of the hazards in both laboratories. The recommended control measure can decrease the severity and likelihood of identified hazards.
Trends in Bacterial and Candida Infections Before and Throughout the COVID-19 Pandemic
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virus, resulted in significant global health consequences. The interventions introduced to limit the spread of the virus had a significant impact on the course of the pandemic, but they might also involve other pathogens besides SARS-CoV-2. This study investigates the epidemiological variations for major bacterial and common fungal pathogens represented by Candida species infection in Qatar through retrospective hospital records. Retrospective data were collected on all bacterial and Candida infections from Hamad General Hospital between January 2019 and December 2021. Statistical analyses were performed using R (Version 4.1.0). Infection count comparisons were performed using chi-square goodness of fit tests. Differences in patient numbers were tested with one-way ANOVA followed by post hoc Tukey HSD. The number of infections and measures were correlated using Spearman rank correlation. The significance level was set at 0.05, and where applicable, the Holm–Bonferroni method was used to correct for multiple testing. The general trend for bacterial and Candida infections showed a significant decrease (p < 0.05) following the imposed restrictions and increases during restriction lifting periods. The number of bacterial infections correlated with the number of international visitors (ρ = 0.61, p < 0.01), while the number of Candida infections correlated with hospital admissions of COVID-19 patients (ρ = 0.59, p = 0.013). The results provide a general overview of the infection trends in Qatar during the COVID-19 pandemic and illustrate some of the pandemic interventions’ effects on bacterial and Candida infections. However, further research is needed to better understand the underlying trend dynamics.
Seroprevalence of small ruminant brucellosis in the state of Qatar
Background Brucellosis is one of the most important zoonotic diseases worldwide, with a significant economic and health burden. The disease is endemic in many regions around the world. Data regarding the disease in the Arabic Gulf region is scarce, and a limited number of studies have been conducted in Qatar. This study is the first to investigate the seroprevalence of small ruminant brucellosis in the state of Qatar. Methods The country was divided into three zones based on animal population (high, medium and low). A total of 494 blood samples from 57 small ruminant flocks were randomly collected from the three zones. Rose Bengal and competitive enzyme‐linked immunosorbent assay were used to investigate the apparent and true seroprevalence at both the animal and flock levels. A regression model was used to investigate the potential risk factors, including geographic zone, sex and age. Results At the animal level, the overall (sheep and goat) apparent and true seroprevalence were 9.6% (95% confidence interval [95% CI]: 7.3–12.5) and 8.4% (95% CI: 5.9–11.5), respectively. In sheep, the apparent seroprevalence was 16.7% (95% CI: 12.5–21.8), and the true seroprevalence was 16.1% (95% CI: 11.6–21.7), whereas in goats, the apparent seroprevalence was 2.4% (95% CI: 1.1–5.2), and the true seroprevalence was 0.7% (95% CI: −0.7 to 3.7). At the flock level, overall, apparent sheep and goat seroprevalence were 19.3% (95% CI: 11.1–31.3), 30.0% (95% CI: 16.1–49.8) and 7.4% (95% CI: 2.1–23.4) and true seroprevalence was 18.9% (95% CI: 10.1–31.9), 30.5% (95% CI: 16.1–49.8) and 6.1% (95% CI: 0.3–23.3) respectively. Univariable regression analysis revealed age as the only significant risk factor in the sampled population. Conclusions Brucella appears to be endemic to small ruminants in Qatar. The findings of this study provide baseline data regarding small ruminant brucellosis in Qatar and will aid in plans to control and eradicate the disease. Brucellosis was found to be endemic in small ruminants in Qatar. The disease is more prevalent in sheep (16.7%) compared to goats (2.4%). The seroprevalence at the flock level was 19.3% in small ruminates (sheep and goat combined), 30.0% in sheep and 7.4% in goats. The disease is more prevalent in Shahaniya and Rayyan municipalities but is present throughout the country among small ruminants. The findings of this study provide baseline data regarding small ruminant brucellosis in Qatar.
E-Cigarette Liquid Provokes Significant Embryotoxicity and Inhibits Angiogenesis
E-cigarette smoking (ECS) is a new method of tobacco smoking that is gaining popularity as it is thought to be a “healthy method” of tobacco consumption. The adverse outcomes of ECS on the respiratory and cardiovascular systems in humans have been recently demonstrated. Nevertheless, the effect of e-cigarette liquid (ECL) on the early stage of embryogenesis and angiogenesis has not been explored yet. Chicken embryo at 3 days of incubation and its chorioallantoic membrane (CAM) of 5 days were used to explore the outcome of ECL on the embryo. Real-time PCR was also employed to study the regulation of a set of key controller genes of embryogenesis as well as angiogenesis. Our study revealed that ECL exposure is associated with a high rate of mortality in embryos as around 70% of treated embryos, at 3 days of incubation, die after 5 days of exposure. Additionally, ECL inhibits angiogenesis of the CAM of 5 days of incubation by more than 30%. These effects could be explained by the upregulation of ATF-3, FOXA2, INHBA, MAPRE-2, and RIPK-1, as well as the downregulation of SERPINA-4 and VEGF-C genes, which are important key controller genes of embryogenesis as well as angiogenesis. Our data suggest clearly that ECS can have dramatic toxic outcomes on the early stage of embryogenesis as well as angiogenesis. Accordingly, we believe that further studies to assess the effects of ECS on human health are essential.
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
COVID-19 complications still present a huge burden on healthcare systems and warrant predictive risk models to triage patients and inform early intervention. Here, we profile 893 plasma proteins from 50 severe and 50 mild-moderate COVID-19 patients, and 50 healthy controls, and show that 375 proteins are differentially expressed in the plasma of severe COVID-19 patients. These differentially expressed plasma proteins are implicated in the pathogenesis of COVID-19 and present targets for candidate drugs to prevent or treat severe complications. Based on the plasma proteomics and clinical lab tests, we also report a 12-plasma protein signature and a model of seven routine clinical tests that validate in an independent cohort as early risk predictors of COVID-19 severity and patient survival. The risk predictors and candidate drugs described in our study can be used and developed for personalized management of SARS-CoV-2 infected patients. Prognostic markers for patients with COVID-19 are of critical importance in determining the course of SARS-CoV-2 infection and patient handling. Here the authors determine and apply a prognostic proteomic panel for risk and drug prediction in the management of SARS-CoV-2 infected patients.
Seroprevalence of camel brucellosis in Qatar
Abstract Brucellosis is a significant zoonotic disease and one of the most common neglected diseases worldwide. It can infect a wide range of domestic and wild animal species. Infected animals are usually culled, causing substantial economic losses to animal owners and the country’s economy in general. The disease is endemic among cattle, sheep, and goats in many countries around the Middle East and prevalent in most Gulf Cooperation Council countries, comprising a significant public health risk in the region. This study investigated the seroprevalence of brucellosis among camels in Qatar. Two hundred and forty-eight samples were collected from dromedary camels from 28 farms across the entire country. Each sample was tested for Brucella antibodies with both Rose Bengal and competitive enzyme-linked immunosorbent assay. Only samples that tested positive by both tests were considered seropositive for brucellosis. The overall prevalence was (20.6%, 95% CI, 15.7–26.1). The association between sex and seropositivity was slightly significant (Χ2 = 4.32, P = 0.04), with higher seroprevalence in females. Camels below breeding age (i.e., < 4 years old) showed decreased seropositivity (3.4%, 95% CI, 0.1–17.8), compared to (22.8%, 95% CI, 17.4–29.0) seropositivity in camels ≥ 4 years of age, with a significant association between age groups and seropositivity (P = 0.02). Our results indicate that the seroprevalence of brucellosis in Qatar’s camels is alarming, mandating more efforts to control the disease. The findings of this study will aid in selecting better effective measures to control camel brucellosis in Qatar. Further studies need to be conducted on Brucella infection among camels to determine the predisposing risk factors and the steps that should be followed to control brucellosis.